These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29366406)

  • 21. Modulation of melanocortin signaling ameliorates uremic cachexia.
    Cheung WW; Rosengren S; Boyle DL; Mak RH
    Kidney Int; 2008 Jul; 74(2):180-6. PubMed ID: 18432186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ShenKang injection suppresses kidney fibrosis and oxidative stress via transforming growth factor-β/Smad3 signalling pathway in vivo and in vitro.
    Wu X; Guan Y; Yan J; Liu M; Yin Y; Duan J; Wei G; Hu T; Weng Y; Xi M; Wen A
    J Pharm Pharmacol; 2015 Aug; 67(8):1054-65. PubMed ID: 25864844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis.
    Li YK; Ma DX; Wang ZM; Hu XF; Li SL; Tian HZ; Wang MJ; Shu YW; Yang J
    Pharmacol Res; 2018 May; 131():102-111. PubMed ID: 29530599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melanocortin-4 receptor antagonist TCMCB07 ameliorates cancer- and chronic kidney disease-associated cachexia.
    Zhu X; Callahan MF; Gruber KA; Szumowski M; Marks DL
    J Clin Invest; 2020 Sep; 130(9):4921-4934. PubMed ID: 32544087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SREBP-1 Mediates Angiotensin II-Induced TGF-β1 Upregulation and Glomerular Fibrosis.
    Wang TN; Chen X; Li R; Gao B; Mohammed-Ali Z; Lu C; Yum V; Dickhout JG; Krepinsky JC
    J Am Soc Nephrol; 2015 Aug; 26(8):1839-54. PubMed ID: 25398788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TGF-β/BMP proteins as therapeutic targets in renal fibrosis. Where have we arrived after 25 years of trials and tribulations?
    Muñoz-Félix JM; González-Núñez M; Martínez-Salgado C; López-Novoa JM
    Pharmacol Ther; 2015 Dec; 156():44-58. PubMed ID: 26493350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ghrelin and cachexia in chronic kidney disease.
    Suzuki H; Asakawa A; Amitani H; Nakamura N; Inui A
    Pediatr Nephrol; 2013 Apr; 28(4):521-6. PubMed ID: 22760416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ameliorative effect of ursolic acid on renal fibrosis in adenine-induced chronic kidney disease in rats.
    Thakur R; Sharma A; Lingaraju MC; Begum J; Kumar D; Mathesh K; Kumar P; Singh TU; Kumar D
    Biomed Pharmacother; 2018 May; 101():972-980. PubMed ID: 29635907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual Therapeutic Effects of an Albumin-Based Nitric Oxide Donor on 2 Experimental Models of Chronic Kidney Disease.
    Oshiro S; Ishima Y; Maeda H; Honda N; Bi J; Kinoshita R; Ikeda M; Iwao Y; Imafuku T; Nishida K; Miyamura S; Watanabe H; Otagiri M; Maruyama T
    J Pharm Sci; 2018 Mar; 107(3):848-855. PubMed ID: 29074377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disparate phospho-Smad2 levels in advanced type 2 diabetes patients with diabetic nephropathy and early experimental db/db mouse model.
    Thomsen LH; Fog-Tonnesen M; Nielsen Fink L; Norlin J; García de Vinuesa A; Hansen TK; de Heer E; Ten Dijke P; Rosendahl A
    Ren Fail; 2017 Nov; 39(1):629-642. PubMed ID: 28805484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melanocortin antagonism ameliorates muscle wasting and inflammation in chronic kidney disease.
    Cheung WW; Mak RH
    Am J Physiol Renal Physiol; 2012 Nov; 303(9):F1315-24. PubMed ID: 22914778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cat as a naturally occurring model of renal interstitial fibrosis: Characterisation of primary feline proximal tubular epithelial cells and comparative pro-fibrotic effects of TGF-β1.
    Lawson JS; Liu HH; Syme HM; Purcell R; Wheeler-Jones CPD; Elliott J
    PLoS One; 2018; 13(8):e0202577. PubMed ID: 30138414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis [seecomments].
    Wolf G; Hamann A; Han DC; Helmchen U; Thaiss F; Ziyadeh FN; Stahl RA
    Kidney Int; 1999 Sep; 56(3):860-72. PubMed ID: 10469355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Connective tissue growth factor expressed in tubular epithelium plays a pivotal role in renal fibrogenesis.
    Okada H; Kikuta T; Kobayashi T; Inoue T; Kanno Y; Takigawa M; Sugaya T; Kopp JB; Suzuki H
    J Am Soc Nephrol; 2005 Jan; 16(1):133-43. PubMed ID: 15574513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy.
    Hu MC; Shi M; Gillings N; Flores B; Takahashi M; Kuro-O M; Moe OW
    Kidney Int; 2017 May; 91(5):1104-1114. PubMed ID: 28131398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and evaluation of anti-renal fibrosis activity of novel truncated TGF-β receptor type II.
    Liu H; Zhang Z; Li Y; Wang X; Zhang Y; Chu Y; Yuan X; Wang X
    Biotechnol Appl Biochem; 2018 Nov; 65(6):834-840. PubMed ID: 30066965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of R128Q mutations in human, ovine, and chicken leptins.
    Raver N; Vardy E; Livnah O; Devos R; Gertler A
    Gen Comp Endocrinol; 2002 Mar; 126(1):52-8. PubMed ID: 11944966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel RAS Inhibitors Poricoic Acid ZG and Poricoic Acid ZH Attenuate Renal Fibrosis via a Wnt/β-Catenin Pathway and Targeted Phosphorylation of smad3 Signaling.
    Wang M; Chen DQ; Chen L; Liu D; Zhao H; Zhang ZH; Vaziri ND; Guo Y; Zhao YY; Cao G
    J Agric Food Chem; 2018 Feb; 66(8):1828-1842. PubMed ID: 29383936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The adipokine leptin mediates muscle- and liver-derived IGF-1 in aged mice.
    Hamrick MW; Dukes A; Arounleut P; Davis C; Periyasamy-Thandavan S; Mork S; Herberg S; Johnson MH; Isales CM; Hill WD; Otvos L; Belin de Chantemèle EJ
    Exp Gerontol; 2015 Oct; 70():92-6. PubMed ID: 26220769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cachexia in children with chronic kidney disease: challenges in diagnosis and treatment.
    Mak RH
    Curr Opin Support Palliat Care; 2016 Dec; 10(4):293-297. PubMed ID: 27258684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.